Pathophysiology of airflow limitation in chronic obstructive pulmonary disease-Reference-Cited by-全球学者库

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

Published:2004-08 Issue:9435 Volume:364 Page:709-721
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hogg James C

Publisher

Elsevier BV

Subject

General Medicine

Reference135 articles.

1. The GOLD Scientific Committee. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary;Pauwels;Am J Respir Crit Care Med,2001

2. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management, and prevention of Chronic Obstructive Pulmonary Disease NHLBI/WHO Workshop Report,2001

3. Site and nature of airways obstruction in chronic obstructive lung disease;Hogg;N Engl J Med,1968

4. Partitioning of pulmonary impedance in excised human and canine lungs;Van Brabandt;J Appl Physiol,1983

5. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure;Yanai;J Appl Physiol,1992

Cited by 942 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small airways in asthma: From inflammation and pathophysiology to treatment response;Respiratory Medicine;2024-02

2. miR-146a regulates emphysema formation and abnormal inflammation in the lungs of two mouse models;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-01-01

3. CD146 deficiency aggravates chronic obstructive pulmonary disease via the increased production of S100A9 and MMP-9 in macrophages;International Immunopharmacology;2024-01

4. Therapeutic effect of phycocyanin on chronic obstructive pulmonary disease in mice;Journal of Advanced Research;2024-01

5. Single-Cell Sequencing of Lung Macrophages and Monocytes Reveals Novel Therapeutic Targets in COPD;Cells;2023-12-05